WHO releases new global guidance targets to curb antibiotic pollution from manufacturing

The World Health Organization (WHO) has introduced its first guidance on managing antibiotic pollution from manufacturing. This guidance, which addresses wastewater and solid waste management, aims to tackle a significant yet often overlooked issue ahead of the United Nations General Assembly (UNGA) High-Level Meeting on antimicrobial resistance (AMR) on September 26, 2024.

Antibiotic pollution can contribute to AMR, compromising the effectiveness of antibiotics worldwide. Despite high levels of pollution, there is little regulation, and existing quality assurance criteria often neglect environmental emissions. Additionally, there is insufficient information on the proper disposal of unused antibiotics.

Pharmaceutical waste from antibiotic production can foster drug-resistant bacteria, posing global health risks. The new guidance provides a scientific foundation for regulators and the public, promoting transparency and robust pollution control standards.

The guidance, developed with international experts and stakeholders, includes targets for reducing AMR risk and addressing environmental damage from antibiotic manufacturing. It emphasizes the need for action on pollution to preserve the effectiveness of antibiotics and protect health.